ALBUQUERQUE – January 5, 2021 – Heart Hospital of New Mexico at Lovelace Medical Center (HHNM) is now enrolling patients in the iCLAS™ U.S. IDE Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Persistent Atrial Fibrillation. The iCLAS catheter device cuts hours off an ablation procedure, leading to a better outcome and faster recovery time for the patient. HHNM is the only site in New Mexico offering this advanced procedure, performed by New Mexico Heart Institute/Lovelace Medical Group electrophysiologists.
"We are pleased to be able to offer this advanced treatment of Atrial Fibrillation to our patients,” said Sean Mazer, M.D., FHRS, FACC, New Mexico Heart Institute/Lovelace Medical Group electrophysiologist. "AFib affects a large portion of our patients and this clinical trial allows us use of the iCLAS device, reducing length of surgery time dramatically and helping the patient heal after surgery quicker for a patient population that can be difficult to treat.”
The One Shot+ Cryoablation Catheter used in the trial makes true continuous, transmural lesions and combines ablation and diagnostics in the same catheter, thereby requiring only a single transseptal puncture. This catheter results in a simplified procedure that utilizes an anatomical approach to guide navigation, eliminating the need for electromagnetic mapping. Interchangeable stylets allow for unlimited shapes of both the ablation and diagnostic sections of the catheter, enabling any targeted lesion set.
"We are privileged to offer this treatment option to our patients," said Derrick Cuenca, chief executive officer of Lovelace Medical Center and Heart Hospital of New Mexico at Lovelace Medical Center. "Our electrophysiologists are among the most highly skilled in the state. They are using some of the world’s most advanced technology, right here in New Mexico to care for our community."
To make an appointment with a New Mexico Heart Institute/Lovelace Medical Group provider, please call 505.841.1000.
Whitney Marquez, Lovelace Health System
Heart Hospital of New Mexico at Lovelace Medical Center
Heart Hospital of New Mexico at Lovelace Medical Center (HH) is New Mexico’s only hospital dedicated exclusively to cardiovascular care, including the State’s only facility performing ventricular aortic device (LVAD) implants and a state-of-the-art hybrid operation room where surgeons can perform advanced surgical services for cardiovascular patients. The 55-bed facility has become synonymous with high quality, technologically-advanced cardiac care in the state. To learn more about the state-of-the-art treatment options, innovative health care providers and award-winning quality initiatives at Heart Hospital of New Mexico at Lovelace Medical Center, visit hearthospitalnm.com.